窪蹋勛圖厙

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 窪蹋勛圖厙 News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Feb 26 2026

Full Issue

New Guidance On Psychotropic Meds Focuses On Deprescribing

The task force convened by the American Society of Clinical Psychopharmacology focused on recognizing situations and circumstances where deprescribing would be appropriate as opposed to the logistics of how to do it. Also in the news: radiation doses from heart scans; the FDA approves a drug for allergic fungal rhinosinusitis; and more.

In a new consensus statement, a task force convened by the American Society of Clinical Psychopharmacology (ASCP) detailed circumstances in which the deprescribing of psychotropic medications may be clinically indicated. (Jeffrey, 2/25)

More pharma and tech developments

Cardiac imaging centers around the world may need to update their protocols and equipment, suggested findings of a large-scale study of radiation effective doses to patients undergoing diagnostic testing for coronary artery disease (CAD). (Lou, 2/25)

Ambulatory surgery centers in November won Medicare coverage for pulsed field ablation. The procedure, which addresses atrial fibrillation, is among several cardiac ablation treatments the Centers for Medicare and Medicaid Services began covering in the setting this year. But ambulatory surgery centers receive lower Medicare payments for the procedure than hospitals do. Despite generally having fewer overhead costs, the centers still need to pay for the expensive equipment, specialized staff and training. (Dubinsky, 2/25)

The FDA approved dupilumab (Dupixent) for treating allergic fungal rhinosinusitis, a first for the condition, the agency announced on Wednesday. Approval stipulates use in individuals 6 years and older with prior sino-nasal surgery, as the condition has a high rate of post-operative recurrence. (Ingram, 2/25)

Two years ago, Megan Selser was folding her 7-week-old infants clothes, clutching his fuzzy red head to her chest, when her phone rang. She answered and heard on the other end the pained voice she had used herself many times as an ICU nurse delivering bad news. (Mast, 2/26)

Novo Nordisk A/S will partner with US biotech firm Vivtex Corp. to develop next-generation drugs for obesity, diabetes and other metabolic diseases in a deal potentially worth up to $2.1 billion. The Danish drugmaker, which is looking to boost its pipeline to find successors to blockbusters Wegovy and Ozempic, said the tie-up will give it access to new technologies that could help it create oral treatments for obesity and other metabolic diseases. (Hipwell, 2/25)

Mike Willis just wants to go to the pub.He wants to stroll down the street, walk into a bar, and shoot the breeze with his friends. But the Cambridge, England, resident cant do that anymore. Over the last six years, Willis, 71, has lost the ability to speak and socialize because of a neurodegenerative disorder.(Broderick, 2/26)

Also

About once a week, Erinne Kennedy, DMD, MPH, treats patients with complex dental infections who need antibiotics. She writes these prescriptions with care, because she knows the harm they can cause. In 2015, Kennedys grandmother suffered multiple infections with a superbug called Clostridioides difficile, also known as C difficileor C diff, which is associated with antibiotic use.Watching her grandmother battle the infection, which kills nearly 30,000 people in the United States each year, was really devastating, said Kennedy, assistant dean for curriculum and integrated learning at Kansas City University College of Dental Medicine in Missouri.(Szabo, 2/25)

If youve ever had a wisdom tooth removed, you probably received an antibiotic from your dentist.Dentists wrote 27.3 million antibiotic prescriptions last year, according to data provided exclusively to CIDRAP News by the IQVIA Institute for Human Data Science, an organization based in Parsippany, New Jersey that provides research and analysis on health care data. Many of these antibiotics are unnecessary. (Szabo, 2/26)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, June 5
  • Thursday, June 4
  • Wednesday, June 3
  • Tuesday, June 2
  • Monday, June 1
  • Friday, May 29
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 窪蹋勛圖厙
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

穢 2026 KFF